The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Stocks•27 April 2026•

1 min read

Elanco Receives U.S. Emergency Authorizations for Screwworm Treatments

Key Facts

1Elanco Animal Health received Emergency Use Authorization (EUA) from the U.S. FDA for Negasunt Powder.

2The U.S. EPA granted a Section 18 Emergency Exemption for Tanidil in cooperation with the USDA.

3The products will be available only through the APHIS National Veterinary Stockpile.

Elanco Animal Health has secured Emergency Use Authorization (EUA) from the U.S. FDA for its Negasunt Powder, aimed at treating livestock infestations. Additionally, the U.S. EPA granted a Section 18 Emergency Exemption for the company's Tanidil product in coordination with the USDA. These regulatory milestones serve as a preemptive response to confirmed cases of New World screwworm detected near the U.S.-Mexico border, posing a significant threat to domestic livestock. The products will be distributed exclusively through the APHIS National Veterinary Stockpile to ensure rapid deployment if needed. This development highlights Elanco's strategic role in national veterinary biosecurity and emergency preparedness. While distribution is limited to government stockpiles, the move reinforces the company's regulatory standing and market leadership in animal health solutions.